Liposomal cytarabine in neoplastic meningitis from primary brain tumors: A single institutional experience

Neurological Sciences

Volumn 34, Issue 12, 2013, Pages 2151-2157

  Gaviani, P ^a   Corsini, E ^a   Salmaggi, A ^a   Lamperti, E ^a   Botturi, A ^a   Erbetta, A ^a   Milanesi, I ^a   Legnani, F ^a   Pollo, B ^a   Silvani, A ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Liposomal cytarabine; Neoplastic meningitis; Primitive brain tumors

Indexed keywords

ANTIBIOTIC AGENT; CISPLATIN; CYTARABINE; DEXAMETHASONE; ETOPOSIDE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASTROCYTOMA; BACKACHE; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CELLS; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; CONSOLIDATION CHEMOTHERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; EPENDYMOMA; FEMALE; GERM CELL TUMOR; HUMAN; INDUCTION CHEMOTHERAPY; LUMBAR PUNCTURE; MALE; MEDULLOBLASTOMA; MELANOMA; MENINGIOMA; MENINGITIS; MENINX DISORDER; MULTIPLE CYCLE TREATMENT; NEOPLASTIC MENINGITIS; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; TERATOCARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; CYTARABINE; FEMALE; HUMANS; LIPOSOMES; MALE; MENINGEAL NEOPLASMS; MENINGITIS; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84890565804     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1358-0     Document Type: Article

References (26)

1. Chamberlain MC (2008) Neoplastic meningitis. Oncologist 13:967-977
2. Bruna J, Gonzalez L, Miro′ J et al (2009) Leptomeningeal carcinomatosis. Cancer 115:381-389
3. Silvani A, Caroli M, Gaviani P, Fetoni V, Merli R, Riva M, De Rossi M, Imbesi F, Salmaggi A (2013) Neoplastic meningitis from solid tumors: a prospective clinical study in Lombardia and a literature review on therapeutic approaches. J Drug Deliv 2013:147325
4. Glantz MJ, Van Horn A, Fisher R, Chamberlain MC (2010) Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis. Cancer 116:1947-1952
5. Rueda Domínguez A, Olmos Hidalgo D, Viciana Garrido R, Torres Sánchez E (2005) Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis. Clin Transl Oncol 7(6):232-238
6. Glantz MJ, Jaeckle KA, Chamberlain MC et al (1999) A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5:3394-3402
7. Chamberlain MC (1998) Leptomeningeal metastases: a review of evaluation and treatment. J Neurooncol 37:271-284
8. Chamberlain MC (2006) Lymphomatous meningitis in primary central nervous system lymphoma. Neurosurg Focus 21(5):E6
9. Strik H, Prömmel P (2010) Diagnosis and individualized therapy of neoplastic meningitis. Expert Rev Anticancer Ther 10(7):1137-1148
10. Gleissner B, Chamberlain MC (2006) Neoplastic meningitis. Lancet Neurol 5(5):443-452
11. Elliott P, Ku NN, Werner MH (1995) Neoplastic meningitis with normal neurological findings magnetic resonance imaging results. J Neuroimaging 5(4):233-236
12. Glantz MJ, Cole BF, Recht L et al (1998) High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 16:1561-1567
13. Boogerd W, Bent MJ, Koehler PJ et al (2004) The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomized study. Eur J Cancer 40:2726-2733
14. Silvani A (2007) Experience with the intrathecal use of liposomal cytarabine at the Besta institute. Tumori 93(3):6-8 suppl
15. Rueda Domínguez A, Olmos Hidalgo D, Viciana Garrido R, Torres Sánchez E (2005) Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis. Clin Transl Oncol 7(6):232-238
16. Esteva FJ, Soh LT, Holmes FA et al (2000) Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer. Cancer Chemother Pharmacol 46:382-386
17. Partap S, Murphy PA, Vogel H et al (2011) Liposomal cytarabine for central nervous system embryonal tumors in children and young adults. J Neurooncol 103(3):561-566
18. Arita N, Taneda M, Hayakawa T (1994) Leptomeningeal dissemination of malignant glioma, incidence, diagnosis and outcome. Acta Neurochir (Wien) 126:84-92
19. D'Haene N, Coen N, Neugroschl C et al (2009) Leptomeningeal dissemination of low grade intramedullary gliomas: about one case and review. Clin Neurol Neurosurg 111:390-394
20. Mazloom A, Hodges JC, The BS et al (2012) Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination. Int J Radiat Oncol Biol Phys 84(2):350-354
21. Nandipati S, Demopoulos A (2011) Leptomeningeal dissemination of anaplastic glioma: prolonged survival in two patients treated with temozolomide. J Neurooncol 105:663-665
22. Passarin MG, Moretto G, Musso AM et al (2010) Intrathecal liposomal cytarabine in combination with temozolomide in low grade oligoastrocytoma with leptomeningeal dissemination. J Neurooncol 97:439-444
23. Jaeckle KA (2006) Neoplastic meningitis from systemic malignancies: diagnosis, prognosis and treatment. Semin Oncol 33(3):312-323
24. Garcia-Marco JA, Panizo C, Garcia ES et al (2009) Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma. Cancer 115(9):1892-1898
25. Benesch M, Siegler N, Hoff K et al (2009) Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study. Anticancer Drugs 20(9):794-799
26. Murry DJ, Blaney SM (2000) Clinical pharmacology of encapsulated sustained-release cytarabine. Ann Pharmacother 34(10):1173-1178